Press Releases Syncona Limited

Equities

BACT

GG00B8P59C08

Delayed London S.E. Other stock markets 03:01:43 2024-06-03 am EDT			5-day change	1st Jan Change
110.3 ^GBX	-0.25%		-0.25%	-10.60%

May. 17	Syncona notes Autolus's first quarter loss widens amid higher costs	AN
May. 09	Syncona's Freeline gets positive results for Gaucher disease	AN

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Syncona : Anaveon announces IND approval of ANV600-001 (EXPAND) Phase I/II clinical study	May. 29	PU
Syncona : Ascend acquires GMP manufacturing capacity in Alachua, Florida; Enters long-term partnership with Beacon Therapeutics for clinical and commercial AAV production	Apr. 09	PU
BEST OF THE BROKERS	Apr. 08	AQ
Syncona : Autolus Therapeutics announces acceptance of Marketing Authorization Application (MAA) by the European Medicines Agency (EMA)	Apr. 02	PU
Syncona : Autolus Therapeutics Announces Changes to its Board of Directors (1)	Apr. 02	PU
Syncona : Anaveon announces publication of ANV419 Phase I data in The Journal for ImmunoTherapy of Cancer	Dec. 14	PU
Syncona to Acquire Freeline Therapeutics	Nov. 22	AQ
Syncona : SwanBio Evolves Leadership Team with Appointment of Executive Chair and Chief Operating Officer	23-10-16	PU
Syncona : Corporate Presentation - October 2023	23-10-10	PU
Syncona : SwanBio Advances to Higher-Dose Cohort in First-in-Human Study of Gene Therapy for Adrenomyeloneuropathy	23-10-04	PU
Syncona : Clade Therapeutics Announces the Acquisition of Gadeta B.V.	23-10-02	PU
Syncona : OMass Therapeutics Adds Mark Namchuk, PhD to Scientific Advisory Board	23-09-27	PU
Syncona : Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer	23-09-06	PU
Syncona : Corporate Presentation - August 2023	23-09-01	PU
Syncona : Quarterly Update covering the period 01 April 2023 to 30 June 2023	23-08-10	PU
Syncona : Purespring Therapeutics appoints Sachin Kelkar as CFO following appointment of Julian Hanak as CEO	23-08-02	PU
Syncona : OMass Therapeutics Expands Leadership Team with Two New Appointments	23-08-02	PU
Syncona : Annual Report for the year ended 31 March 2023	23-06-28	PU
Syncona : Resolution Therapeutics Strengthens its Team with Senior Appointments	23-06-26	PU
Syncona : Full Year Results for the 12 months ended 31 March 2023	23-06-15	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Syncona Limited

Equities

BACT

GG00B8P59C08

Press Releases

Filters